Clinician-Reported Barriers and Needs for Implementation of Continuous Glucose Monitoring

References

1. 1.↵
   American Diabetes Association. National Diabetes Statistics Report, 2020. Available at: https://www.cdc.gov/diabetes/php/data-research/index.html#:~:text=Among%20US%20adults%20aged%2020,see%20U.S.%20Diabetes%20Surveillance%20System).
2. 2.↵
   1. Carls G,
   2. Huynh J,
   3. Tuttle E,
   4. Yee J,
   5. Edelman SV

   . Achievement of glycated hemoglobin goals in the US remains unchanged through 2014. Diabetes Ther 2017;8:863–73.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Khunti K,
   2. Ceriello A,
   3. Cos X,
   4. De Block C

   . Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: a meta-analysis. Diabetes Res Clin Pract 2018;137:137–48.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Beck RW,
   2. Riddlesworth T,
   3. Ruedy K

   , DIAMOND Study Groupet al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA 2017;317:371–8.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Evans M,
   2. Welsh Z,
   3. Ells S,
   4. Seibold A

   . The impact of flash glucose monitoring on glycaemic control as measured by HbA1c: a meta-analysis of clinical trials and real-world observational studies. Diabetes Ther 2020;11:83–95.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Gilbert TR,
   2. Noar A,
   3. Blalock O,
   4. Polonsky WH

   . Change in hemoglobin A1c and quality of life with real-time continuous glucose monitoring use by people with insulin-treated diabetes in the landmark study. Diabetes Technol Ther 2021;23:S35–S39.

   OpenUrlPubMed
7. 7.↵
   1. Ida S,
   2. Kaneko R,
   3. Murata K

   . Utility of real-time and retrospective continuous glucose monitoring in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. J Diabetes Res 2019;2019:4684815.

   OpenUrlPubMed
8. 8.↵
   1. Kieu A,
   2. King J,
   3. Govender RD,
   4. Östlundh L

   . The benefits of utilizing continuous glucose monitoring of diabetes mellitus in primary care: a systematic review. J Diabetes Sci Technol 2023;17:762–74.

   OpenUrlPubMed
9. 9.↵
   1. Martens T,
   2. Beck RW,
   3. Bailey R

   , MOBILE Study Groupet al. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. JAMA 2021;325:2262–72.

   OpenUrlCrossRefPubMed
10. 10.↵
    American Diabetes Association. CGM & time in range. 2024; Available at: https://www.diabetes.org/healthy-living/devices-technology/cgm-time-in-range. Accessed January 8, 2024.
11. 11.↵
    American Diabetes Association Professional Practice Committee. Diabetes technology: standards of care in diabetes—2024. Diabetes Care 2024;47(S1):S126–S144.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Oser SM,
    2. Oser TK

    . Diabetes technologies: we are all in this together. Clin Diabetes 2020;38:188–9.

    OpenUrlFREE Full Text
13. 13.↵
    1. Grant RW,
    2. Buse JB,
    3. Meigs JB

    , University HealthSystem Consortium Diabetes Benchmarking Project T. Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care 2005;28:337–442.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Unger J,
    2. Kushner P,
    3. Anderson JE

    . Practical guidance for using the FreeStyle Libre flash continuous glucose monitoring in primary care. Postgrad Med 2020;132:305–13.

    OpenUrlCrossRef
15. 15.↵
    1. Mayberry LS,
    2. Guy C,
    3. Hendrickson CD,
    4. McCoy AB,
    5. Elasy T

    . Rates and correlates of uptake of continuous glucose monitors among adults with type 2 diabetes in primary care and endocrinology settings. J Gen Intern Med 2023;38:2546–52.

    OpenUrlPubMed
16. 16.↵
    Certification Board for Diabetes Care and Education. 2024; Available at: https://www.cbdce.org/.
17. 17.↵
    1. Bhide M,
    2. Grey JM,
    3. Moser EG,
    4. Garg SK

    . A primary care perspective on the use of continuous glucose monitoring in clinical practice. Diabetes Technol Ther 2013;15:533-7.
18. 18.↵
    1. Mahoney D,
    2. Salama L

    . Enhancing patient-centered care through firsthand experience with continuous glucose monitoring in rural Wyoming. Ann Fam Med 2024;22:69.

    OpenUrlFREE Full Text
19. 19.↵
    1. Martens TW

    . Continuous glucose monitoring in primary care–are we there? Current Opinion in Endocrinology & Diabetes and Obesity 2022;29:10–6.

    OpenUrl
20. 20.↵
    1. Rodbard D

    . Continuous glucose monitoring: a review of successes, challenges, and opportunities. Diabetes Technol Ther 2016;18:S2–3-S2-13.

    OpenUrlPubMed
21. 21.↵
    1. Wood A,
    2. O'Neal D,
    3. Furler J,
    4. Ekinci EI

    . Continuous glucose monitoring: a review of the evidence, opportunities for future use and ongoing challenges. Intern Med J 2018;48:499–508.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Aleppo G,
    2. Webb K

    . Continuous glucose monitoring integration in clinical practice: a stepped guide to data review and interpretation. J Diabetes Sci Technol 2019;13:664–73.

    OpenUrlPubMed
23. 23.↵
    1. Oser TK,
    2. Hall TL,
    3. Dickinson LM,
    4. et al

    . Continuous glucose monitoring in primary care: understanding and supporting clinicians’ use to enhance diabetes care. Ann Fam Med 2022;20:541–7.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Onwuegbuzie AJ,
    2. Collins KM

    . A typology of mixed methods sampling designs in social science research. Qualitative Report 2007;12:281–316.

    OpenUrl
25. 25.↵
    1. Hamilton A

    . Qualitative methods in rapid turn-around health services research. Health Services Research & Development Cyberseminar 2013; Available at: https://www.hsrd.research.va.gov/for_researchers/cyber_seminars/archives/video_archive.cfm?SessionID=780. Accessed February 26, 2024.
26. 26.↵
    1. Palinkas LA,
    2. Mendon SJ,
    3. Hamilton AB

    . Innovations in mixed methods evaluations. Annu Rev Public Health 2019;40:423–42.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Zehra A,
    2. Brown EA,
    3. Wolf RM

    . Providing point-of-care sample CGM increases uptake of personal CGM. J Diabetes Sci Technol 2023;17:598–9.

    OpenUrlPubMed
28. 28.↵
    Centers for Medicare and Medicaid Services. Medicare coverage database. 2024.
29. 29.↵
    1. Tanenbaum ML,
    2. Adams RN,
    3. Lanning MS,
    4. et al

    . Using cluster analysis to understand clinician readiness to promote continuous glucose monitoring adoption. J Diabetes Sci Technol 2018;12:1108–15.

    OpenUrlPubMed
30. 30.↵
    1. Pickup JC,
    2. Ford Holloway M,
    3. Samsi K

    . Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives. Diabetes care 2015;38:544–50.

    OpenUrlAbstract/FREE Full Text
31. 31.↵
    1. Filippi MK,
    2. Lanigan AM,
    3. Oser SM,
    4. Alai J,
    5. Brooks-Greisen A,
    6. Oser TK

    . A team-based training for continuous glucose monitoring in diabetes care: mixed methods pilot implementation study in primary care practices. JMIR Form Res 2023;7:e45189.

    OpenUrl